Philips & United States

Philips: Philips released its Future Health Index 2026 report, highlighting the significant impact of AI in healthcare and its role in conducting this global survey.

United States: The report specifically focuses on the United States>>> healthcare system, detailing how AI is transforming clinical care within the country. The findings are relevant to healthcare providers and policymakers across the United States>>>.

Philips: Philips received FDA 510(k) clearance for its Elevate Plus ultrasound system, enhancing its position in AI-powered health technology and potentially increasing sales and market share.

United States: The United States is the market where Philips received regulatory clearance for its Elevate Plus system, allowing its use in the country.

Philips: Philips has entered into a seven-year strategic alliance with WellSpan Health, becoming its preferred vendor for imaging modalities and co-developing new healthcare technology. This collaboration is expected to drive innovation and expand Philips' market presence in the US healthcare system.

United States: The collaboration is noted as the first of its kind between Philips and a US community health system, indicating a potential model for future healthcare innovation within the country.

Philips: Philips is identified as a leading company in both the Sleep Tech Devices Market and Sleep Apnea Devices Market, holding the second-largest share in the latter.

Philips: Wingtech — Nexperia was once part of the Dutch electronics group Philips before being acquired by Wingtech.